Summary
Boston Scientific Corporation (BSX) filed an 8-K on October 24, 2013, to report its financial results for the third quarter ended September 30, 2013. The filing primarily serves to furnish a press release announcing these results, which is attached as Exhibit 99.1. Investors should refer to this press release for detailed financial performance metrics, including revenue, profitability, and any forward-looking guidance provided by the company. This report signifies a routine disclosure of quarterly financial performance. While the 8-K itself does not contain the financial figures, the attached press release is the key document for understanding BSX's operational and financial condition during the third quarter of 2013. Investors are encouraged to review the press release for specific details on business segment performance, any significant operational developments, and management's commentary on future prospects.
Key Highlights
- 1Boston Scientific Corporation filed an 8-K report on October 24, 2013.
- 2The report pertains to the financial results for the third quarter ended September 30, 2013.
- 3The primary purpose of the filing is to furnish the press release announcing these financial results.
- 4The press release is attached as Exhibit 99.1 to the 8-K.
- 5Information contained within this Item 2.02 filing and its exhibit is not considered 'filed' for certain regulatory purposes, limiting liability under Section 18 of the Exchange Act.
- 6Investors need to refer to the accompanying press release (Exhibit 99.1) for the actual financial data and operational details.
- 7This filing marks a standard quarterly earnings announcement.